Significant Jury Awards for Transvaginal Mesh Plaintiffs
Significant jury awards continue to be handed down for plaintiffs who filed transvaginal mesh lawsuits. One of the more recent awards involves Boston Scientific. The company was found liable for causing significant injuries to a woman who can no longer sit, walk, or exercise without excruciating pain after enduring four surgeries as a result of her transvaginal mesh implant. The… Read more »
Thinking of Selling Your Structured Settlement?
Many plaintiffs are awarded compensation for damages they’ve incurred in the form of structured settlements. Rather than receiving one lump sum payment, they are compensated through periodic payments spread out over a period of time. Some people prefer this method, as it helps to keep to better manage their money, as they do not have the ability to recklessly spend… Read more »
Boehringer Ingelheim Agrees to Pay $650 in Pradaxa Settlements
Pradaxa manufacturer Boehringer Ingelheim announced last month that it has agreed to pay $650 million to settle thousands of lawsuits involving the blood thinning medication. More than 4,000 cases against the company are currently pending in state and federal courts. The settlement will likely resolve most of them. Plaintiffs accuse Boehringer of causing patients to suffer severe and sometimes even… Read more »
GM Considering Compensating All Victims of Faulty Ignition Switch Accidents
General Motors is working to create a plan that may provide compensation to all victims injured as a result of a faulty ignition switch ─ regardless of when their accident occurred. An attorney representing the plaintiffs noted that GM’s compensation expert, Kenneth Feinberg said he plans to propose some form of compensation for all victims, whether or not their accident… Read more »
How an Actos Settlement Loan Can Assist Plaintiffs
A $9 billion jury award in a recent Actos lawsuit may be one of the largest awards in U.S. history. The decision came after the jury determined Actos manufacturer Takeda failed to properly warn consumers and the medical community about potential cancer risks associated with their drug. Although the decision is good news to others who have been injured by… Read more »
